Immunome Inc. SEC filings IMNM
Immunome Inc. has 460 filings in SEC EDGAR's recent list, going back to Sep 14, 2009. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 5, 2026 | Oct 2, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Other events
|
Dec 17, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 15, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 12, 2025 | May 8, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Other events
|
Jan 30, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 29, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 23, 2025 | Jan 21, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Unregistered share sale
|
Oct 29, 2024 | Oct 25, 2024 |
| 8-K |
Current report
Other events
|
Oct 8, 2024 | Oct 3, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 30, 2024 | Apr 24, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 25, 2024 | Apr 25, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
|
Mar 26, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Other events
|
Feb 14, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 13, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 6, 2024 | Feb 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 1, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2024 | Jan 11, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 8, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 2, 2024 | Jan 2, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 29, 2023 | Dec 22, 2023 |
| 8-K |
Current report
Other events
|
Dec 26, 2023 | Dec 22, 2023 |
| 8-K/A | Amended current report | Nov 22, 2023 | Sep 29, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 15, 2023 | Nov 15, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 8, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Oct 4, 2023 | Sep 29, 2023 |
| 8-K |
Current report
Other events
|
Sep 21, 2023 | Sep 21, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Other events
|
Jul 5, 2023 | Jul 5, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 29, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Results of operations
|
May 5, 2023 | May 5, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Other events
|
Jan 30, 2023 | Jan 30, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 6, 2023 | Jan 4, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 6, 2023 | Jan 4, 2023 |
| 8-K |
Current report
Other events
|
Nov 15, 2022 | Nov 15, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Auditor change
|
Oct 6, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Sep 2, 2022 | Sep 2, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2022 | Aug 5, 2022 |
| 8-K |
Current report
Other events
|
Jul 6, 2022 | Jul 6, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 9, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Other events
|
May 19, 2022 | May 19, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2022 | Mar 28, 2022 |
| 8-K |
Current report
Other events
|
Mar 11, 2022 | Mar 11, 2022 |
| 8-K |
Current report
Other events
|
Feb 8, 2022 | Feb 8, 2022 |
| 8-K |
Current report
Other events
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Other events
|
Nov 29, 2021 | Nov 29, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 18, 2021 | Oct 18, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 21, 2021 | Sep 21, 2021 |
| 8-K |
Current report
Other events
|
Sep 8, 2021 | Sep 7, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 5, 2021 | Aug 1, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 20, 2021 | Jul 20, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 17, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Jun 1, 2021 | May 27, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
May 20, 2021 | May 19, 2021 |
| 8-K |
Current report
Results of operations
|
May 12, 2021 | May 12, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 26, 2021 | Apr 26, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 26, 2021 | Apr 26, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 20, 2021 | Apr 19, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 29, 2021 | Mar 29, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2021 | Mar 25, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 16, 2021 | Mar 15, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 4, 2020 | Nov 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 17, 2020 | Nov 17, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 26, 2020 | Oct 26, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 6, 2020 | Oct 6, 2020 |
Showing 83 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMNM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bothell, WA
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1472012
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.